» Articles » PMID: 24884783

Differential Binding of Neutralizing and Non-neutralizing Antibodies to Native-like Soluble HIV-1 Env Trimers, Uncleaved Env Proteins, and Monomeric Subunits

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2014 Jun 3
PMID 24884783
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutralizing antibodies (NAbs). No candidate HIV-1 immunogen has yet induced potent, broadly active NAbs (bNAbs). Part of the explanation may be that previously tested Env proteins inadequately mimic the functional, native Env complex. Trimerization and the proteolytic processing of Env precursors into gp120 and gp41 profoundly alter antigenicity, but soluble cleaved trimers are too unstable to serve as immunogens. By introducing stabilizing mutations (SOSIP), we constructed soluble, cleaved Env trimers derived from the HIV-1 subtype A isolate BG505 that resemble native Env spikes on virions both structurally and antigenically.

Results: We used surface plasmon resonance (SPR) to quantify antibody binding to different forms of BG505 Env: the proteolytically cleaved SOSIP.664 trimers, cleaved gp120-gp41ECTO protomers, and gp120 monomers. Non-NAbs to the CD4-binding site bound only marginally to the trimers but equally well to gp120-gp41ECTO protomers and gp120 monomers, whereas the bNAb VRC01, directed to the CD4bs, bound to all three forms. In contrast, bNAbs to V1V2 glycan-dependent epitopes bound preferentially (PG9 and PG16) or exclusively (PGT145) to trimers. We also explored the antigenic consequences of three different features of SOSIP.664 gp140 trimers: the engineered inter-subunit disulfide bond, the trimer-stabilizing I559P change in gp41ECTO, and proteolytic cleavage at the gp120-gp41ECTO junction. Each of these three features incrementally promoted native-like trimer antigenicity. We compared Fab and IgG versions of bNAbs and validated a bivalent model of IgG binding. The NAbs showed widely divergent binding kinetics and degrees of binding to native-like BG505 SOSIP.664. High off-rate constants and low stoichiometric estimates of NAb binding were associated with large amounts of residual infectivity after NAb neutralization of the corresponding BG505.T332N pseudovirus.

Conclusions: The antigenicity and structural integrity of cleaved BG505 SOSIP.664 trimers render these proteins good mimics of functional Env spikes on virions. In contrast, uncleaved gp140s antigenically resemble individual gp120-gp41ECTO protomers and gp120 monomers, but not native trimers. Although NAb binding to functional trimers may thus be both necessary and sufficient for neutralization, the kinetics and stoichiometry of the interaction influence the neutralizing efficacy of individual NAbs.

Citing Articles

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site.

Caniels T, Medina-Ramirez M, Zhang S, Kratochvil S, Xian Y, Koo J Sci Immunol. 2024; 9(98):eadk9550.

PMID: 39213338 PMC: 11783328. DOI: 10.1126/sciimmunol.adk9550.


Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis.

Basu S, Gohain N, Kim J, Trinh H, Choe M, Joyce M Cells. 2024; 13(1).

PMID: 38201237 PMC: 10778174. DOI: 10.3390/cells13010033.


Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.

Ringe R, Colin P, Ozorowski G, Allen J, Yasmeen A, Seabright G PLoS Pathog. 2023; 19(10):e1011601.

PMID: 37903160 PMC: 10635575. DOI: 10.1371/journal.ppat.1011601.


Modulation of immune responses to liposomal vaccines by intrastructural help.

Damm D, Suleiman E, Wagner J, Klessing S, Pfister F, Elsayed H Eur J Pharm Biopharm. 2023; 192:112-125.

PMID: 37797679 PMC: 10872448. DOI: 10.1016/j.ejpb.2023.10.003.


Kennedy Epitope (KE)-dependent Retrograde Transport of Efficiently Cleaved HIV-1 Envelopes (Envs) and its Effect on Env Cell Surface Expression and Viral Particle Formation.

DAS S, Parray H, Chiranjivi A, Kumar P, Goswami A, Bansal M Protein J. 2023; 43(2):375-386.

PMID: 37794304 DOI: 10.1007/s10930-023-10161-1.


References
1.
Zeder-Lutz G, Hoebeke J, Van Regenmortel M . Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies. Eur J Biochem. 2001; 268(10):2856-66. DOI: 10.1046/j.1432-1327.2001.02167.x. View

2.
Binley J, Sanders R, CLAS B, Schuelke N, Master A, Guo Y . A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol. 2000; 74(2):627-43. PMC: 111582. DOI: 10.1128/jvi.74.2.627-643.2000. View

3.
Yang X, Lee J, Mahony E, Kwong P, Wyatt R, Sodroski J . Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. J Virol. 2002; 76(9):4634-42. PMC: 155086. DOI: 10.1128/jvi.76.9.4634-4642.2002. View

4.
Hessell A, Rakasz E, Poignard P, Hangartner L, Landucci G, Forthal D . Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 2009; 5(5):e1000433. PMC: 2674935. DOI: 10.1371/journal.ppat.1000433. View

5.
Liu L, Cimbro R, Lusso P, Berger E . Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A. 2011; 108(50):20148-53. PMC: 3250183. DOI: 10.1073/pnas.1104840108. View